164 related articles for article (PubMed ID: 9049584)
1. Effect of route of administration of fluconazole on the interaction between fluconazole and midazolam.
Ahonen J; Olkkola KT; Neuvonen PJ
Eur J Clin Pharmacol; 1997; 51(5):415-9. PubMed ID: 9049584
[TBL] [Abstract][Full Text] [Related]
2. The effects of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.
Olkkola KT; Ahonen J; Neuvonen PJ
Anesth Analg; 1996 Mar; 82(3):511-6. PubMed ID: 8623953
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.
Krishna G; Moton A; Ma L; Savant I; Martinho M; Seiberling M; McLeod J
Clin Ther; 2009 Feb; 31(2):286-98. PubMed ID: 19302901
[TBL] [Abstract][Full Text] [Related]
4. Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam.
Palkama VJ; Ahonen J; Neuvonen PJ; Olkkola KT
Clin Pharmacol Ther; 1999 Jul; 66(1):33-9. PubMed ID: 10430107
[TBL] [Abstract][Full Text] [Related]
5. Effect of fluconazole dose on the extent of fluconazole-triazolam interaction.
Varhe A; Olkkola KT; Neuvonen PJ
Br J Clin Pharmacol; 1996 Oct; 42(4):465-70. PubMed ID: 8904618
[TBL] [Abstract][Full Text] [Related]
6. The effect of intravenous and oral fluconazole on the pharmacokinetics and pharmacodynamics of intravenous alfentanil.
Palkama VJ; Isohanni MH; Neuvonen PJ; Olkkola KT
Anesth Analg; 1998 Jul; 87(1):190-4. PubMed ID: 9661572
[TBL] [Abstract][Full Text] [Related]
7. Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.
Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT
Clin Pharmacol Ther; 2006 Apr; 79(4):362-70. PubMed ID: 16580904
[TBL] [Abstract][Full Text] [Related]
8. Fluconazole, but not terbinafine, enhances the effects of triazolam by inhibiting its metabolism.
Varhe A; Olkkola KT; Neuvonen PJ
Br J Clin Pharmacol; 1996 Apr; 41(4):319-23. PubMed ID: 8730978
[TBL] [Abstract][Full Text] [Related]
9. 150 mg fluconazole does not substantially increase the effects of 10 mg midazolam or the plasma midazolam concentrations in healthy subjects.
Vanakoski J; Mattila MJ; Vainio P; Idänpään-Heikkilä JJ; Törnwall M
Int J Clin Pharmacol Ther; 1995 Sep; 33(9):518-23. PubMed ID: 8520811
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam.
Shord SS; Chan LN; Camp JR; Vasquez EM; Jeong HY; Molokie RE; Baum CL; Xie H
Br J Clin Pharmacol; 2010 Feb; 69(2):160-6. PubMed ID: 20233179
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation.
Backman JT; Mäenpää J; Belle DJ; Wrighton SA; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2000 Apr; 67(4):382-90. PubMed ID: 10801247
[TBL] [Abstract][Full Text] [Related]
12. Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174.
Kaukonen KM; Olkkola KT; Neuvonen PJ
Eur J Clin Pharmacol; 1998 Feb; 53(6):445-9. PubMed ID: 9551703
[TBL] [Abstract][Full Text] [Related]
13. Effects of metronidazole on midazolam metabolism in vitro and in vivo.
Wang JS; Backman JT; Kivistö KT; Neuvonen PJ
Eur J Clin Pharmacol; 2000 Nov; 56(8):555-9. PubMed ID: 11151744
[TBL] [Abstract][Full Text] [Related]
14. Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole.
Kivistö KT; Lamberg TS; Kantola T; Neuvonen PJ
Clin Pharmacol Ther; 1997 Sep; 62(3):348-54. PubMed ID: 9333111
[TBL] [Abstract][Full Text] [Related]
15. The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin.
Backman JT; Kivistö KT; Olkkola KT; Neuvonen PJ
Eur J Clin Pharmacol; 1998 Mar; 54(1):53-8. PubMed ID: 9591931
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pharmacokinetic interactions between oral fluconazole and intravenous ketamine and midazolam in dogs.
Berke K; KuKanich B; Orchard R; Rankin D; Joo H
Vet Anaesth Analg; 2019 Nov; 46(6):745-752. PubMed ID: 31401049
[TBL] [Abstract][Full Text] [Related]
17. Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
Dingemanse J; van Gerven JM; Schoemaker RC; Roncari G; Oberyé JJ; van Oostenbruggen MF; Massarella J; Segala P; Zell M; Cohen AF
Br J Clin Pharmacol; 1997 Nov; 44(5):477-86. PubMed ID: 9384465
[TBL] [Abstract][Full Text] [Related]
18. A potentially hazardous interaction between erythromycin and midazolam.
Olkkola KT; Aranko K; Luurila H; Hiller A; Saarnivaara L; Himberg JJ; Neuvonen PJ
Clin Pharmacol Ther; 1993 Mar; 53(3):298-305. PubMed ID: 8453848
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers.
Mandema JW; Tuk B; van Steveninck AL; Breimer DD; Cohen AF; Danhof M
Clin Pharmacol Ther; 1992 Jun; 51(6):715-28. PubMed ID: 1611810
[TBL] [Abstract][Full Text] [Related]
20. Effects of ursodeoxycholic acid on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam in healthy volunteers.
Yan D; Yang Y; Uchida S; Misaka S; Luo J; Takeuchi K; Inui N; Yamada S; Ohashi K; Watanabe H
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):629-36. PubMed ID: 18157519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
